PITTSBURGH — Maine and 29 other states have reached an $8 million settlement with Bayer Corp. over allegations the drug maker failed to adequately warn consumers about risks associated with a cholesterol-reducing drug.
...
Bayer has not admitted any wrongdoing, but has agreed to register relevant clinical drug trials and drug studies and to post the results of those studies online.
Bayer, which voluntarily withdrew Baycol from the market in August 2001, also is prohibited from making false or misleading claims in the future marketing, promotion and sale of its products. It must pay $8 million to the 30 states for future consumer protection and enforcement programs.
In addition to Maine and Pennsylvania, the settlement includes Arizona, Arkansas, California, Connecticut, Delaware, Florida, Idaho, Illinois, Iowa, Kansas, Kentucky, Maryland, Massachusetts, Michigan, Mississippi, Montana, Nevada, North Carolina, Ohio, Oregon, South Carolina, South Dakota, Tennessee, Texas, Vermont, Virginia, Washington and Wisconsin.
http://news.mainetoday.com/apwire/D8MR5PNO0-22.html